chr10-84232056-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015613.3(LRIT1):āc.1743G>Cā(p.Glu581Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015613.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRIT1 | NM_015613.3 | c.1743G>C | p.Glu581Asp | missense_variant | 4/4 | ENST00000372105.4 | |
LRIT1 | XM_011539626.3 | c.1158G>C | p.Glu386Asp | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRIT1 | ENST00000372105.4 | c.1743G>C | p.Glu581Asp | missense_variant | 4/4 | 1 | NM_015613.3 | P1 | |
RGR | ENST00000652073.1 | c.-567-311C>G | intron_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251320Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135854
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461852Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727218
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.1743G>C (p.E581D) alteration is located in exon 4 (coding exon 4) of the LRIT1 gene. This alteration results from a G to C substitution at nucleotide position 1743, causing the glutamic acid (E) at amino acid position 581 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at